Ann Clin Microbiol 2021;24:115-126. Trends in Isolation and Antimicrobial Susceptibility of Enteropathogenic Bacteria in 2011-2019 at a Korean Tertiary Care Hospital Compared with Data in the Preceding Reports
| Year | No. of patients | % of isolates susceptible to: | |||||
|---|---|---|---|---|---|---|---|
| AMP | CHL | SXT | CTX | CAZ | FQN* | ||
| 1979 – 1983 | 211 | 98 | 99 | 100 | NT | NT | NT |
| 1984 – 1988 | 337 | 54 | 64 | 98 | NT | NT | NT |
| 1989 – 1993 | 420 | 67 | 77 | 90 | NT | NT | NT |
| 1994 – 1998 | 865 | 76 | NT | 90 | 98 | 98 | 100 |
| 2001 – 2005 | 210 | 65 | NT | 93 | 99 | 100 | 100 |
| 2006 – 2010† | 141 | 61 | NT | 92 | 96 | 98 | 98 |
| 2011 – 2015 | 108 | 53 | NT | 93 | 92 | 92 | 84 |
| 2016 – 2019 | 153 | 51 | NT | 85 | 74 | 81 | 73 |
*FQN: ofloxacin (1994-1996), levofloxacin (1997-1998), levofloxacin (2001-2010) and levofloxacin (2011-2019).
†The data from 1969-2010 were adapted from reference [7].
Abbreviation: AMP, ampicillin; CHL, chloramphenicol; SXT, sulfamethoxazole-trimethoprim; CTX, cefotaxime; CAZ, ceftazidime; FQN, fluoroquinolone; NT, not tested.